Alembic Pharmaceuticals Limited announces USFDA Final Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
15th January, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from...